{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:25:30Z","timestamp":1785173130375,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["# 26218663"],"award-info":[{"award-number":["# 26218663"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.pop.2018.02.005","type":"journal-article","created":{"date-parts":[[2018,5,12]],"date-time":"2018-05-12T00:59:47Z","timestamp":1526086787000},"page":"271-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["The Seronegative Spondyloarthropathies"],"prefix":"10.1016","volume":"45","author":[{"given":"Ayyappa S.","family":"Duba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie D.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pop.2018.02.005_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00005792-197409000-00002","article-title":"Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome","volume":"53","author":"Moll","year":"1974","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.pop.2018.02.005_bib2","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/acr.22831","article-title":"Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis","volume":"68","author":"Stolwijk","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.pop.2018.02.005_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/annrheumdis-2012-201403","article-title":"The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009\u201310","volume":"72","author":"Weisman","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.pop.2018.02.005_bib4","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/art.1780401015","article-title":"Susceptibility to ankylosing spondylitis in twins the role of genes, HLA and the environment","volume":"40","author":"Brown","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.pop.2018.02.005_bib5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/art.24483","article-title":"The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort","volume":"60","author":"Rudwaleit","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pop.2018.02.005_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-immunol-032414-112110","article-title":"HLA-B27","volume":"33","author":"Bowness","year":"2015","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"10.1016\/j.pop.2018.02.005_bib7","first-page":"1181","article-title":"Evaluation and treatment of acute low back pain","volume":"74","author":"Kinkade","year":"2004","journal-title":"Am Fam Physician"},{"issue":"2","key":"10.1016\/j.pop.2018.02.005_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.21619","article-title":"Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria","volume":"54","author":"Rudawaleit","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pop.2018.02.005_bib9","series-title":"Kelley and Firestein's textbook of rheumatology","first-page":"1256","article-title":"Ankylosing spondylitis","author":"van der Linden","year":"2017"},{"issue":"3","key":"10.1016\/j.pop.2018.02.005_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0037-198X(96)80030-7","article-title":"The seronegative spondyloarthropathies","volume":"31","author":"Kettering","year":"1996","journal-title":"Semin Roentgenol"},{"issue":"143","key":"10.1016\/j.pop.2018.02.005_bib11","first-page":"38","article-title":"Radiology of seronegative spondyloarthropathies","author":"Resnick","year":"1979","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"10.1016\/j.pop.2018.02.005_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pop.2018.02.005_bib13","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing spondylitis and axial spondyloarthropathies","volume":"374","author":"Taurog","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.pop.2018.02.005_bib14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1586\/1744666X.2015.1052795","article-title":"Monitoring ankylosing spondylitis: clinically useful markers and prediction of clinical outcomes","volume":"11","author":"Braun","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.pop.2018.02.005_bib15","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"238","key":"10.1016\/j.pop.2018.02.005_bib16","first-page":"127","article-title":"Psoriatic arthritis (PSA): an analysis of 220 patients","volume":"62","author":"Gladman","year":"1987","journal-title":"Q\u00a0J Med"},{"issue":"5","key":"10.1016\/j.pop.2018.02.005_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","article-title":"Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics","volume":"69","author":"Mease","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.pop.2018.02.005_bib18","first-page":"586","article-title":"HLA antigens in psoriatic arthritis","volume":"13","author":"Gladman","year":"1986","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.pop.2018.02.005_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/rheumatology\/30.4.245","article-title":"Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patient","volume":"30","author":"Torre","year":"1991","journal-title":"Br J Rheumatol"},{"issue":"2","key":"10.1016\/j.pop.2018.02.005_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/rheumatology\/33.2.133","article-title":"Classification of clinical subsets in psoriatic arthritis","volume":"33","author":"Veale","year":"1994","journal-title":"Br J Rheumatol"},{"issue":"5","key":"10.1016\/j.pop.2018.02.005_bib21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2012-201706","article-title":"High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires","volume":"72","author":"Haroon","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pop.2018.02.005_bib22","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1136\/ard.2004.032318","article-title":"Classification and diagnostic criteria for psoriatic arthritis","volume":"64","author":"Helliwell","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.pop.2018.02.005_bib23","first-page":"511","article-title":"Antibodies to cyclic citrullinated peptides in psoriatic arthritis","volume":"32","author":"Bogliolo","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.pop.2018.02.005_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/187152811304140915152102","article-title":"An update on disease modifying antirheumatic drugs","volume":"13","author":"Joshi","year":"2014","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.pop.2018.02.005_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaut.2016.10.009","article-title":"Management of psoriatic arthritis: early diagnosis, monitoring of disease severity and cutting-edge therapies","volume":"76","author":"Raychaudhuri","year":"2017","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.pop.2018.02.005_bib26","first-page":"1251","article-title":"New GRAPPA and EULAR recommendations for the management of psoriatic arthritis: process and challenges faced","volume":"56","author":"Coates","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pop.2018.02.005_bib27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.rdc.2015.07.010","article-title":"Biologic therapies for psoriatic arthritis","volume":"41","author":"Mease","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.pop.2018.02.005_bib28","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","article-title":"Psoriatic arthritis and psoriasis: classification, clinical features, pathophysiology, immunology, genetics. Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.pop.2018.02.005_bib29","first-page":"270","article-title":"Clinical and genetic associations of radiographic sacroiliitis and its different patterns in psoriatic arthritis","volume":"35","author":"Haroon","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"suppl 93","key":"10.1016\/j.pop.2018.02.005_bib30","first-page":"21","article-title":"Inflammatory bowel disease and spondyloarthropathy","volume":"42","author":"Gionchetti","year":"2015","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.pop.2018.02.005_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12178-011-9085-8","article-title":"Inflammatory bowel disease associated arthropathy","volume":"4","author":"Arvikar","year":"2011","journal-title":"Curr Rev Musculoskelet Med"},{"key":"10.1016\/j.pop.2018.02.005_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07853890.2016.1195011","article-title":"Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases","volume":"48","author":"Colia","year":"2016","journal-title":"Ann Med"},{"key":"10.1016\/j.pop.2018.02.005_bib33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.36076\/ppj.2015\/18\/599","article-title":"Coxib safety in patients with inflammatory bowel disease: a meta-analysis","volume":"18","author":"Ribaldone","year":"2015","journal-title":"Pain Physician"},{"key":"10.1016\/j.pop.2018.02.005_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11894-016-0487-z","article-title":"Crohn\u2019s disease: evolution, epigenetics and the emerging role of microbiome targeted therapies","volume":"18","author":"DeFilippis","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"issue":"3","key":"10.1016\/j.pop.2018.02.005_bib35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.berh.2011.01.018","article-title":"Reactive arthritis","volume":"25","author":"Hannu","year":"2011","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.pop.2018.02.005_bib36","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/ard.61.10.911","article-title":"Annual incidence of inflammatory joint diseases in a population based study in Southern Sweden","volume":"61","author":"S\u00f6derlin","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.pop.2018.02.005_bib37","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/art.27394","article-title":"Combination antibiotics as a treatment for chronic chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial","volume":"62","author":"Carter","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.pop.2018.02.005_bib38","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/1529-0131(199911)42:11<2325::AID-ANR10>3.0.CO;2-C","article-title":"Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondyloarthropaties","volume":"42","author":"Clegg","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pop.2018.02.005_bib39","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/art.30272","article-title":"Safety and efficacy of anti-tumor necrosis factor alpha therapy in then patients with recent-onset refractory reactive arthritis","volume":"63","author":"Meyer","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.pop.2018.02.005_bib40","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.berh.2006.08.008","article-title":"Infection and musculoskeletal conditions: reactive arthritis","volume":"20","author":"Rihl","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.pop.2018.02.005_bib41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780250302","article-title":"Follow up study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27","volume":"25","author":"Leirisalo","year":"1982","journal-title":"Arthritis Rheum"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454318300101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454318300101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T13:11:41Z","timestamp":1751634701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454318300101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0095454318300101"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2018.02.005","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Seronegative Spondyloarthropathies","name":"articletitle","label":"Article Title"},{"value":"Primary Care: Clinics in Office Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pop.2018.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}